今年最令人震惊的临床试验失败：降低Lp(a)没降心血管疾病风险

SummaryAI generated

2026 年 9 月 9 日，一项旨在验证通过干预手段降低低密度脂蛋白(a)[Lp(a)]水平对心血管结局改善作用的临床试验结果公布。该研究未能证明降低 Lp(a) 水平能有效降低心血管疾病风险，目标未达成。这一结果挑战了此前认为降低 Lp(a) 可显著减少心血管事件的主流观点，表明单纯降低该指标未必能有效预防心脏病发作或中风等严重并发症。

Related eventsRELATED EVENTS

2026-09-08 08:00Xiaomi released its first mid-foldable phone, the 18 Fold, with a starting price of 10,999 yuan, and a ceramic special edition available for 15,999 yuan.
2026-09-08 08:43WenTai Technology refuted the rumor that its founder had “run away” and filed a lawsuit; Zhou Xiaoping, general manager of Xingyu Co., Ltd., was suspended from her salary for 12 months
2026-09-09 04:55Meta launched the AI agent Muse: To take control of digital life in response to privacy and trust crises

Key entitiesKEY ENTITIES

Cardiovascular diseasesLp(a)

Coverage · reports per dayLANGUAGE SPLIT

Entity relations

SignalsSIGNALS

Keyword heat

Lp(a)1
Cardiovascular diseases1

All reports (1)SOURCES

↗

虎虎嗅 zh 2026-09-09 08:58

今年一项关于降低 Lp(a) 水平的临床试验未能证明其能降低心血管疾病风险。该研究旨在验证通过干预手段降低低密度脂蛋白(a) 对心血管结局的改善作用，但结果显示目标未达成。这一结果挑战了此前认为降低 Lp(a) 可显著减少心血管事件的主流观点，表明单纯降低该指标未必能有效预防心脏病发作或中风等严重并发症。